CV Sciences, Inc. formed an ongoing partnership with Alkemist Labs to collaborate with the National Institute of Standards and Technology (NIST) on efforts to help cannabis testing labs demonstrate and improve measurement capabilities and comparability.
CV Sciences, Inc. (San Diego, CA) formed an ongoing partnership with Alkemist Labs to collaborate with the National Institute of Standards and Technology (NIST) on efforts to help cannabis testing labs demonstrate and improve measurement capabilities and comparability.
Further, the tools created by this partnership will support measurements establishing legal, commerce, and safety claims through the development of fit-for-purpose analytical methodologies, production of Reference Materials, and implementation of NIST’s Cannabis Quality Assurance Program (CannaQAP).
“As one of the first accredited cannabis testing labs in California, Alkemist Labs has a long history as a strong advocate for rigorous laboratory standards for cannabis products,” said Alkemist Labs CEO Elan Sudberg, in a press release. “We’re very pleased to be partnering with CV Sciences and NIST on this important effort to ensure that labs have the fit-for-purpose test methods they need to support high quality standards of cannabis products.”
CannaQAP will improve the accuracy and capability of cannabis product testing. It will also benefit:
“As the most trusted hemp-derived CBD company, CV Sciences was honored to be invited to partner with Alkemist Labs to assist NIST in its efforts to improve cannabis testing throughout the industry,” said Douglas Mackay, ND, senior vice president of scientific and regulatory affairs for CV Sciences. “We are dedicated to moving the CBD industry forward through science and advancing NIST’s CannaQAP program will play a pivotal role in helping the industry improve the scientific rigor and reproducibility between Cannabis testing labs.”
FDA revokes authorization to use Red No. 3 as a color additive in food or drugs
January 15th 2025FDA contends that the color additive is safe for humans but is legally obligated by the Delaney Clause of the FD&C act to revoke authorization as research shows the Red No. 3 induces cancer in rats.